back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-13 21:23 Tx date 2026-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$144,937
+9,087 vol $15.95 each |
304,166 | |
| Filed 2026-09-13 21:21 Tx date 2026-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-335,364.70
-21,026 vol $15.95 each |
219,938 | |
| Filed 2026-08-25 23:46 Tx date 2026-08-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-713,622.44
-42,052 vol $16.97 each |
240,964 | |
| Filed 2026-08-25 23:37 Tx date 2026-08-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$357,676
+21,077 vol $16.97 each |
295,079 | |
| Filed 2026-08-25 23:22 Tx date 2026-08-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+360 vol |
274,002 | |
| Filed 2026-06-12 13:27 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2026-06-12 13:26 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2026-06-12 13:24 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
274,811 | ||
| Filed 2026-06-12 13:24 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
324,814 | ||
| Filed 2026-06-12 13:23 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,239,039 | ||
| Filed 2026-06-12 13:22 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang Capital Management, LLC
3 - 10% Security Holder of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,205,442 | ||
| Filed 2026-06-08 19:28 Tx date 2026-06-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Nova, Tina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$374,998
+23,931 vol $15.67 each |
87,655 | |
| Filed 2026-06-08 19:25 Tx date 2026-06-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Goetz, Kathleen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$374,998
+23,931 vol $15.67 each |
87,655 | |
| Filed 2026-06-08 19:20 Tx date 2026-06-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Johnson, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$374,998
+23,931 vol $15.67 each |
93,104 | |
| Filed 2026-06-08 19:14 Tx date 2026-06-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$374,998
+23,931 vol $15.67 each |
109,016 | |
| Filed 2026-06-03 14:53 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Options
70 - Acquisition or disposition (writing) of third party derivative
|
$8,250
+5,000 vol $1.65 each |
5,000 | |
| Filed 2026-06-03 14:51 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 14:51 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Options
70 - Acquisition or disposition (writing) of third party derivative
|
$8,250
+5,000 vol $1.65 each |
5,000 | |
| Filed 2026-06-03 13:36 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 12:32 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,573,870
+103,002 vol $15.28 each |
274,811 |